期刊文献+

温通法对S_(180)荷瘤小鼠相关调控基因的影响 被引量:1

Effect on S_(180) Tumor-Burdened Mice Genetically Related Regulation by Wentong Method
下载PDF
导出
摘要 目的探讨温通法对S180荷瘤鼠的抑瘤机制,为其临床应用提供理论依据。方法建立昆明种小鼠S180肉瘤模型50个。随机分为中药高剂量组、中药中剂量组、中药低剂量组、荷瘤对照组、CTX化疗组。通过SP免疫组化法检测S180肿瘤细胞各组Bcl-2、P53基因蛋白表达情况。结果 Bcl-2蛋白和P53蛋白在荷瘤对照组与中药中剂量组、中药高剂量组、CTX组的表达比较均有显著差异,其中与中药中剂量组比较有统计学意义(P<0.05),与中药高剂量组、CTX化疗组比较有显著统计学意义(P<0.01);中药高剂量组与CTX化疗组比较均无显著性差异(P>0.05)。结论温通法抑瘤机制可能是通过抑制P53基因突变,下调Bcl-2蛋白的表达水平实现的。 Objective Exploring WenTong method to tumor-burdened rat S180unti-tumor mechanism,in order to provide the theory basis for its clinical application.Method:Making 50 the Kunming-mice S180sarcoma models.They were randomly divided into high,middle,low dose group traditional Chinese medicine group,a tumor-burdened control group,CTX chemotherapy group.Detecting S180 tumor cell in Bcl-2,P53 protein gene expression by through the SP immunohistochemical method.Results:Compared to high,middle dose group traditional Chinese medicine group,CTX chemotherapy group,the tumor-burdened control group had improvince in Bcl-2 protein gene expression(P〈0.05).Compared to high dose group traditional Chinese medicine group,CTX chemotherapy group,the tumor-burdened control group had signifikently improvince(P〈0.01).High dose group traditional Chinese medicine group and CTX chemotherapy group have no difference(P〈0.05).Conclusion:The unti-tumor mechanism may be that WenTong method can inhibiting P53 gene mutations,cut down Bcl-2 protein expression level.
出处 《光明中医》 2013年第1期36-38,共3页 GUANGMING JOURNAL OF CHINESE MEDICINE
基金 河南省基础与前沿技术研究(No:082300450130)
关键词 温通法 S180肉瘤 抑瘤机制 bcl-2 P53 中医肿瘤学 WenTong method S180 sarcoma unti-tumor mechanism BCL-2 P53 TCM oncology
  • 相关文献

参考文献10

  • 1邸若虹,李永健.应用温阳法辨治肿瘤述要[J].中医药学刊,2001,19(5):471-472. 被引量:5
  • 2刘嘉湘,施志明,徐振晔,韩明权,朱晏伟,高虹,陈善香,赵丽红,李和根,朱惠蓉,刘苓霜.滋阴生津益气温阳法治疗晚期原发性肺腺癌的临床研究[J].中医杂志,1995,36(3):155-158. 被引量:151
  • 3李永健,方肇勤.温阳法在肿瘤治疗中的应用与思考[J].中医药学报,2001,29(2):1-3. 被引量:28
  • 4杨亚琴,朱世航.温通法对S_(180)荷瘤小鼠的抑瘤作用的实验研究[J].光明中医,2010,25(7):1160-1161. 被引量:2
  • 5Sulzer MA, Leers MP, Van Moord JA, et al. Reduced E cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non small cell lung cancer[ J]. Am J Respir Cri Care Med, 1998, 157(4) :1319-1323.
  • 6Volta M, Koomagi R, Mattern J. Prognostic value of vascular endothelial growth factor and its receptor Fit 1 in squamous cell lung cancer[ J]. Int J Cancer, 1997, 74( 1 ) :64-68.
  • 7Korsmeyer SJ. Bcl-2initiates a new category of oncogenes: regulators of cell death[J]. Blood 1992,80(4) :879-886.
  • 8Marin MC,Hsu B,Meyn RE,et al. Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis [ J ]. Oncogene 1994,9 ( 11 ) : 3107-3112.
  • 9Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene [ J ]. Cell, 1995,80 (2) :293-199.
  • 10Reich NC,Levine AJ. Growth regulation of cellular tumour antigen, p53, innontransformed cells [ J ]. Nature, 1984, 308 ( 5955 ) : 199-201.

二级参考文献23

共引文献170

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部